InsourceInfusion
Revenue Cycle

Intelligent Revenue Recovery

Stop leaving money on the table. AI predicts denials before they happen, generates optimized claims, and automates appeals—protecting every dollar of your high-cost drug revenue.

  • Pre-submission claim scrubbing with AI
  • Denial prediction before claims are submitted
  • Automated appeal generation for denials
  • Buy-and-bill inventory optimization
  • Contract rate compliance monitoring
  • 15-40% reduction in revenue leakage
Revenue — InsourceInfusion

MTD Billed

$1.2M

↑ 8% vs last month

Collected

$847K

71% collection rate

Pending

$289K

42 claims in process

At Risk

$64K

8 denials pending

Revenue Trend

Billed Collected
Oct
Nov
Dec
Jan

AI Revenue Insights

3 actions
Cigna underpaying Remicade by $2,400/claim (12 affected)
$28.8K
3 claims approaching timely filing deadline
$18.2K
AI-generated appeals recovered $42K this month
+$42K